Shop

Spinal Muscular Atrophy (SMA) is a story that brings together genetic discovery, neurological science, and rehabilitation innovation. For years, SMA was considered a relentlessly progressive neuromuscular disease with few available treatment options. Disorders that have traditionally been viewed as poor prognosis with limited meaningful life many now intersect at the interface of genetics and therapy, where advances in molecular genetics, early diagnosis via newborn screening, and disease-modifying therapies are transforming both prognosis and functional expectations. As such, these medical innovations and advancements provide an enormous challenge for rehabilitative professionals —especially physiotherapists —to evolve, grow and optimize clinical practice. SMA individuals now live longer, achieve developmental milestones once thought impossible, and enter adolescence and adulthood with changing functional requirements. Physiotherapy wan thus transformed from a predominantly passive and preventive health care delivery system to an active, dynamic, and life-long treatment oriented model. In light of this increasing gap, this book was created: a focused, evidence based and clinically relevant resource to aid physiotherapy management in SMA. It marries basic knowledge of genetics and pathophysiology with applied rehabilitation science to develop approaches that encompass:  Early neurodevelopmental intervention  Functional motor training and strengthening  Respiratory physiotherapy  Orthopedic management and deformity prevention  Assistive technology and mobility solutions  Fatigue and pain management  Psychosocial and vocational transition